A comparison of cancer detection rates between template systematic biopsies obtained using MRI-US fusion machine and freehand transrectal ultrasound-guided systematic biopsies.

JOURNAL OF ENDOUROLOGY(2020)

引用 3|浏览12
暂无评分
摘要
Introduction:There are reports that the 12-core template systematic biopsies (SBx) obtained by using software registration machines (e.g., Artemis) have higher cancer detection rates (CDRs) of prostate cancer (PCa) than the standard, freehand 12-core transrectal ultrasound (TRUS)-guided biopsies. The goal of our study is to compare the clinically significant (CS) CDRs of SBx in two independent cohorts who underwent freehand TRUS-SBx alone (Cohort A) or machine-guided SBx as part of a combined MRI-ultrasound (MRI-US) fusion biopsy (FBx) (Cohort B). Materials and Methods:A retrospective review of all patients undergoing prostate biopsies over a 4-year period at the University of Cincinnati Medical Center was performed. CS cancer was defined as having a Gleason score >= 7. MRI-US FBx were obtained by using an Artemis software registration device (ARTEMIS (TM), Eigen, Inc., Grass Valley, CA). Statistical significance was considered atp < 0.05. Results:Nine hundred and thirty men underwent SBx (Cohort A: 474, Cohort B: 456). There were no statistical differences between cohort A and B in CS CDRs in the overall population (39.3%vs33.8%;p = 0.093), biopsy naive patients (40.4%vs39.8%;p = 0.951), or patients with a prior negative biopsy (22.7%vs25.0%;p = 0.910). Multivariate logistic regression controlling for age, race, prostate-specific antigen level, prostate volume, abnormal digital rectal exam, and family history of PCa demonstrated comparable CS CDRs, which was maintained when further stratified by prior biopsy history (all patients: odds ratio [OR] 0.99, 95% confidence interval [CI] 0.71-1.38,p = 0.958; biopsy naive: OR 0.79, 95% CI 0.51-1.22,p = 0.291; prior negative biopsy: OR 0.64, 95% CI 0.21-1.75,p = 0.403). Conclusions:Our study did not find a significant difference in the CS CDRs of machine-guided SBx compared with the freehand TRUS-SBx. Unless the SBx is done at the time of FBx, the use of these machines for obtaining SBx only is unlikely to result in any increase of CS CDRs.
更多
查看译文
关键词
fusion biopsy,multiparametric MRI-US fusion biopsy,systematic biopsy,prostate cancer,transrectal ultrasound
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要